Mettler-Toledo International, Inc. $MTD Shares Purchased by Koshinski Asset Management Inc.

Koshinski Asset Management Inc. boosted its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 23.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 492 shares of the medical instruments supplier’s stock after buying an additional 95 shares during the period. Koshinski Asset Management Inc.’s holdings in Mettler-Toledo International were worth $578,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the company. Greenleaf Trust boosted its position in Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock valued at $1,030,000 after buying an additional 10 shares during the last quarter. Brooklyn Investment Group boosted its position in Mettler-Toledo International by 12.8% in the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 10 shares during the last quarter. Sax Wealth Advisors LLC boosted its position in Mettler-Toledo International by 2.8% in the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock valued at $437,000 after buying an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in Mettler-Toledo International by 1.8% in the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock valued at $740,000 after buying an additional 11 shares during the last quarter. Finally, Albion Financial Group UT boosted its position in Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock valued at $890,000 after buying an additional 11 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at $6,389,588.55. This represents a 5.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 165 shares of the company’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider directly owned 94 shares of the company’s stock, valued at approximately $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock valued at $2,371,208 in the last three months. 0.77% of the stock is currently owned by company insiders.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,351.15 on Monday. The company has a market cap of $27.83 billion, a price-to-earnings ratio of 34.21, a PEG ratio of 4.05 and a beta of 1.37. The stock has a 50 day simple moving average of $1,287.35 and a 200-day simple moving average of $1,195.77. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,438.46.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. The business had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the company posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently commented on MTD. Bank of America upped their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Evercore ISI upped their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Barclays upped their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Citigroup upped their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Thursday, August 21st. Finally, JPMorgan Chase & Co. upped their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,336.50.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.